Eli Lilly (NYSE:LLY) has partnered with Collaborative Drug Discovery to make its AI drug discovery platform, Lilly TuneLab, ...

Biotech companies that use CDD Vault will be able to utilize select Lilly predictive models within their natural scientific ...

Collaborative Drug Discovery (CDD), the leading provider of data management solutions for the pharmaceutical and ...

Eli Lilly has developed artificial intelligence models that can help predict the behavior of potential drug candidates, based on the data the drugmaker has collected over the last two decades and at ...

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced a collaboration with Lilly TuneLab™, a platform launched by Eli Lilly and Company (Lilly) designed to accelerate drug ...

Eli Lilly is inviting early-stage biotechs to make use of drug discovery models that the pharma is providing via a new AI platform. The machine learning platform, called Lilly TuneLab, allows selected ...

(RTTNews) - Eli Lilly and Company (LLY) Tuesday said it has launched TuneLab, an artificial intelligence and machine learning (AI/ML) platform to provide biotechnology companies access to drug ...

INDIANAPOLIS, Sept. 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the launch of Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform that ...

Eli Lilly and Company (LLY) on Tuesday announced the launch of an artificial intelligence and machine learning platform called Lilly TuneLab. The platform provides biotech companies access to drug ...

SAN MATEO, Calif.--(BUSINESS WIRE)--BigHat Biosciences, a protein therapeutics company that combines state-of-the-art AI models with a high-speed automated wet lab, today announced a collaboration ...

(RTTNews) - Eli Lilly and Co. (LLY), a pharmaceutical company, on Tuesday announced the launch of Lilly TuneLab, an artificial intelligence and machine learning platform designed to give biotech ...